Q3e: group CR of 83.7% and group adj PTP of EUR 464m. Adj. EPS '24e +2% and '25e-'26e -4% (mainly int. rate-driven). We argue that its UW skills deserve a premium valuation: BUY.
High price increases in non-life = margin expansion; Attractive dividend levels to come from life units; BUY stability from Sampo/Tryg; earnings growth STB/GJF
Underlying and reported UW in line, while financials beat. Adj. EPS up 1% for '25e-'26e, while '24e up by 7% from the beat. Cap. adj. P/E in '26e at 11x (15% discount to peers) and yield of ~23%.
If P&C's underlying CR +5% vs ABG, and much better financials. Reported CR (If P&C) a tad better at 83.1% (fire in DK). Cons.24e (+2-4% amid financials), 25e-26e (+1%); stock just up
A more normal claims quarter should start to show the repricing. Expanding margins up avg. adj EPS '25e-'26e by ~1%. Prefer Sampo to Tryg and GJF (all BUYs); TOP (SELL)
Q2e: offer for Top, share buyback, premium growth & fire headwind. Adj. EPS '24e -1% (financials & associates), '26e -1% (Hastings). We continue to argue for a premium valuation for Sampo: BUY
Repeat its profitable growth, price and cost discipline. Weather effects of 7.2pp in Q1'24 give hope of improved 2H. No estimate changes, ~10% upside to TP of NOK 195, BUY.
Underl. CR of 87%, in line with ABGSCe, rep. 3pp worse (weather). Adj EPS'24e-25e unchanged, '26e +3% on better underlying UW. Cap. adj. P/E'25e 12.3x (10% discount to peers) and yield of 25.9%.
If P&C's underlying CR in line with ABG, much better financials. Reported CR (If P&C) weaker at 86.7% hit by tough Nordic weather. Cons.24e (+0-2% amid financials), 25e-26e intact; stock end up +1%.